Sequent Asset Management’s Quest Diagnostics DGX Stock Holding History

Sequent Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$495K	Sell	2,336 -356	-13%	-$69.9K	0.21%	54
2026 Q1	$528K	Hold	2,692	–	–	0.25%	52
2025 Q4	$467K	Hold	2,692	–	–	0.21%	55
2025 Q3	$513K	Hold	2,692	–	–	0.24%	52
2025 Q2	$484K	Hold	2,692	–	–	0.39%	44
2025 Q1	$455K	Hold	2,692	–	–	0.25%	51
2024 Q4	$406K	Hold	2,692	–	–	0.2%	55
2024 Q3	$418K	Hold	2,692	–	–	0.21%	55
2024 Q2	$368K	Hold	2,692	–	–	0.19%	59
2024 Q1	$358K	Sell	2,692 -250	-8%	-$32.4K	0.19%	53
2023 Q4	$406K	Sell	2,942 -2,000	-40%	-$263K	0.24%	49
2023 Q3	$602K	Hold	4,942	–	–	0.66%	26
2023 Q2	$695K	Sell	4,942 -2,306	-32%	-$318K	0.75%	25
2023 Q1	$1.03M	Hold	7,248	–	–	1.16%	21
2022 Q4	$1.13M	Hold	7,248	–	–	0.76%	22
2022 Q3	$889K	Sell	7,248 -8	-0.1%	-$1.05K	0.67%	27
2022 Q2	$964K	Buy	+7,256	New	+$989K	0.71%	27

Other funds holding DGX

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sequent Asset Management's DGX Position: Q2 2026 in Review

Sequent Asset Management reduced its Quest Diagnostics (DGX) stake by 13% in Q2 2026, selling an estimated $69.9K and leaving 2,336 shares worth $495K. The position accounts for 0.21% of the portfolio, ranked #54.

Sequent Asset Management first reported a position in DGX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.13M in Q4 2022. 405 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Sequent Asset Management held 2,336 shares of Quest Diagnostics worth $495K as of Q2 2026.
Sequent Asset Management sold 356 Quest Diagnostics shares in Q2 2026, an estimated $69.9K.
Quest Diagnostics made up 0.21% of Sequent Asset Management's portfolio in Q2 2026, its #54 holding.
Sequent Asset Management first reported a position in Quest Diagnostics in Q2 2022 and has held it in 17 quarters since.
Sequent Asset Management's Quest Diagnostics position peaked at $1.13M in Q4 2022.
405 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Sequent Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.